Who we are ?

Immunostat Oncology Pty Ltd is a private biotechnology company, focused on developing and commercialising a promising targeted cancer immunotherapy, known as CpG-STAT3siRNA (CPG), being developed at the prestigious City of Hope Comprehensive Cancer Centre in Los Angeles.